/
ATEC
$9.50+$0.20 (+2.15%)prev close
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.4B
154M shares
52-week range
$6.82 – $23.29
16% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-5.72
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $91.7M | $113.4M | $144.9M | $243.2M | $350.9M | $482.3M | $611.6M | $764.2M |
| Cost of revenue | $28.5M | $35.8M | $42.4M | $85.5M | $117.8M | $172.1M | $187.3M | $232.3M |
| Gross profit | $63.2M | $77.6M | $102.5M | $157.8M | $233.1M | $310.2M | $424.3M | $531.9M |
| Gross margin | 69.0% | 68.4% | 70.8% | 64.9% | 66.4% | 64.3% | 69.4% | 69.6% |
| R&D | $10.0M | $13.8M | $18.7M | $32.0M | $44.0M | $70.1M | $80.7M | $76.3M |
| Operating income | −$22.4M | −$47.3M | −$58.9M | −$128.1M | −$147.0M | −$173.4M | −$136.2M | −$82.1M |
| EBITDA | −$13.2M | −$38.8M | −$54.8M | −$106.9M | −$102.6M | −$110.6M | −$53.9M | −$39.7M |
| Net income | −$29.0M | −$57.0M | −$79.0M | −$143.0M | −$151.3M | −$186.6M | −$162.1M | −$143.4M |
| Net margin | -31.6% | -50.3% | -54.5% | -58.8% | -43.1% | -38.7% | -26.5% | -18.8% |
| EPS (diluted) | -0.82 | -1.09 | -1.18 | -1.50 | -1.47 | -1.54 | -1.13 | -0.96 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $882M | $0.32 | $0.30–$0.33 | 5 |
| 2027 | $1.0B | $0.58 | $0.55–$0.60 | 5 |
| 2028 | $1.2B | $0.86 | $-0.05–$2.32 | 3 |
| 2029 | $1.4B | $1.20 | $1.17–$1.27 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$14.39
Price
$9.50
Implied upside
+51%
Peer comparison
Alphatec Holdings, Inc.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
www.atecspine.com- Employees
- 913
- IPO / List date
- Jun 2, 2006
- HQ
- CARLSBAD, CA
Held by traders on TradeandTell
No one on the platform currently holds ATEC.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,055,100 | $11.5M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2016-08-25 | 1-for-12reverse |
Recent trades on TradeandTell
No one on the platform has traded ATEC yet.
